![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Cadchem Laboratories Limited Chandigarh In, based in India, is a pharmaceutical company.
One of their significant offerings is Levetiracetam, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-318 - Rev 00
This Chemical Type CEP, issued on May 03, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2535 associated with this CEP further emphasizes